rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Avantor, Inc.

AVTR · NYSE

Health CareLife-science toolsLeading

AVTR stood above a rising 150-day average in 12 of the last 52 weekly readings, including each of the last 12 weeks. It is 47.4% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
12 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$11.4M
Insider sales, 12 months
$0
Officials’ trades on record
22
Institutions holding
427 (+27)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$3.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

22 disclosed lines: House 18, Senate 0, executive 4; 6 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k22 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k28 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k18 Mar 2026filed 14 May 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k12 Feb 2026filed 14 May 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k13 Aug 2025filed 12 Sep 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k12 Aug 2025filed 12 Sep 2025
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k23 Jul 2025filed 14 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k17 Jun 2025filed 13 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k11 Jun 2025filed 13 Aug 2025
John James House: U.S. House ClerkMI10sold$1k–$15k4 Sep 2024filed 6 Sep 2024
John James House: U.S. House ClerkMI10bought$1k–$15k10 Nov 2023filed 2 Sep 2024
Daniel S. Goldman House: U.S. House ClerkNY10sold$1k–$15k12 Jul 2023filed 13 Aug 2023

Insiders

Buy orders, 12 months8
Sale orders, 12 months0
Buyers · sellers5 · 0
WhoDidSharesTraded
Gregory T. LucierDirectorbought10,000at $8.328 May 2026filed 11 May 2026
Simon DingemansDirectorbought25,000at $8.141 May 2026filed 5 May 2026
Sanjeev K. MehraDirectorbought125,000at $8.0110 Mar 2026filed 11 Mar 2026
Gregory T. LucierDirectorbought50,000at $9.1619 Feb 2026filed 23 Feb 2026
Gregory L. SummeDirectorbought100,000at $9.4012 Feb 2026filed 12 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders427+27 on the quarter
New · exited95 · 68
Reported value$6.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Dodge & Coxadded · filed 13 Aug 2026120,020,974$1.2B+372,645+0.3%
BlackRock, Inc.added · filed 7 Aug 202670,281,231$695.8M+4,577,677+7.0%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202631,343,250$310.3M+67,403+0.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202630,802,835$304.9M+196,723+0.6%
GREENHAVEN ASSOCIATES INCadded · filed 28 Jul 202624,637,310$243.9M+2,043,472+9.0%
STATE STREET CORPadded · filed 7 Aug 202621,572,974$213.6M+851,895+4.1%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 202620,412,181$202.1M+3,517,532+20.8%
Engine Capital Management, LPadded · filed 14 Aug 202619,860,830$196.6M+80,000+0.4%
BARROW HANLEY MEWHINNEY & STRAUSS LLCreduced · filed 12 Aug 202619,735,968$195.4M-2,622,431−11.7%
New Mountain Capital, L.L.C.unchanged · filed 14 Aug 202614,000,000$138.6M00.0%
31 Mar 2023 – 30 Jun 2026
375417458Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Todd W. Garner Company insiderEVP and CFO · last 21 Sep 20260 · 0
Emmanuel Ligner Company insiderPresident and CEO · last 18 Aug 20261 · 0
Brittany Hankamer Company insiderEVP, Chief HR Officer · last 14 Aug 20260 · 0
Steven W. Eck Company insiderSVP & Chief Accounting Officer · last 31 Jul 20260 · 7
Claudius Sokenu Company insiderEVP, Chief Legal & Compliance · last 24 Jul 20260 · 0
Corey Walker Company insiderPresident, VWR Dist. & Servs. · last 21 Jun 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 22 May 20263 · 1
Gregory T. Lucier Company insiderDirector · last 8 May 20262 · 0
Gregory L. Summe Company insiderDirector · last 7 May 20267 · 0
Joseph R. Massaro Company insiderDirector · last 7 May 20261 · 0
Louise Makin Company insiderDirector · last 7 May 20260 · 0
Mala Murthy Company insiderDirector · last 7 May 20260 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202532.7%
Operating profit marginFY 2025 · to 31 Dec 2025-3.8%
Free cash flow marginFY 2025 · to 31 Dec 20257.6%
Return on capital employedFY 2025 · to 31 Dec 2025-2.4%
Debt to equityFY 2025 · to 31 Dec 20250.71×
Share count trendFY 2025 · to 5 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$365.4M
Free cash flowFY 2025 · to 31 Dec 2025$495.0M

Analyst forecasts

No analyst forecasts yet.